Product Matches
- New Product Spotlight: Linagliptin and EmpagliflozinIncidence of diabetes has been growing worldwide over the last 20 years. Due to ...
- A0249BAM-22P
Peptide, cleavage product of proenkephalin; κOR and μOR agonist.
≥95% - A0248BAM-12P
Peptide, cleavage product of proenkephalin; κOR agonist.
≥95% - A5275[Des-Asp1]-Angiotensin I, human
Peptide, derivative of AT I, cleavage product of angiotensin, precursor to AT...
≥95% - A5272Angiotensin, dog/rat
Peptide, derivative of AT I, cleavage product of angiotensin, precursor to AT...
≥95% - A4854β-Amyloid Peptide (1-42), rat
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - Piperlongumine Suppresses Pancreatic Tumor GrowthPiperlongumine is found in several species of the Piper plant and displays many ...
- A4853β-Amyloid Peptide (1-42), human
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4852β-Amyloid Peptide (1-40)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4851β-Amyloid Peptide (1-40), rat
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - B807214Buflomedil Hydrochloride
Alpha blocker and vasoactive agent.
≥99% - A5276Angiotensin I, human
Endogenous peptide, cleavage product of angiotensin, precursor to angiotensin...
≥98% - Active Compounds in Bee Venom and Their Biomedical ApplicationsBee venom is a complex mixture of enzymes, polypeptides, amino acids, and sugars...
- A4849Amyloid-β (25-35)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4848Amyloid-β (1-40)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥98% - Palmatine and Pancreatic CancerPalmatine is an isoquinoline alkaloid naturally found in plant species such as ...
- P698583Prostaglandin E2
principal metabolic product of COX-2
≥98% - Six New Products for the New YearLKT Labs continues to expand its catalog with six new compounds for the new year...
- LRRK2 Inhibitors Available from LKT Laboratories, Inc.Leucine-rich repeat kinase 2 (LRRK2) is an important target in the treatment of ...
- S1343Ac-SDKP
Peptide, degradation product of thymosin B4, involved in hematopoiesis.
≥95%